Pilic Larisa, Molkentin Kira, Lehmann Lion, Herrmann Alina, Funke Christian, Müller Beate Sigrid, Bödecker August-Wilhelm, Redaèlli Marcus, Wilm Stefan
Institut für Allgemeinmedizin, Universitätsklinikum Köln, Köln, Deutschland.
Institut für Allgemeinmedizin, Universitätsklinikum Köln, Köln, Deutschland.
Z Evid Fortbild Qual Gesundhwes. 2024 Apr;185:45-53. doi: 10.1016/j.zefq.2023.12.003. Epub 2024 Feb 28.
The majority of patients in disease management programs (DMPs) for type 2 diabetes (T2DM) and coronary heart disease (CHD) in Germany are enrolled by their general practitioner (GP). The aim of this study was, in the context of upcoming DMP expansions, to elicit GPs' current experiences and opinions regarding the perceived effectiveness and acceptance of the DMPs T2DM and CHD, as well as to determine beneficial and hindering aspects of the implementation of these programs from a GP's perspective.
In August and September 2020, 20 GPs of teaching practices of the University Hospital Cologne with experiences in DMPs were interviewed in semi-structured focus group discussions. Their expectations, attitudes and opinions regarding the DMPs T2DM and CHD were evaluated and analyzed according to the content-structuring qualitative content analysis by Kuckartz.
The DMP T2DM was rated as generally positive by the respondents due to the structured treatment including regular foot and eye examinations, close patient contacts and perceptions of improved health outcomes. The DMP CHD was rated more negatively by the respondents because of a high and partly unnecessary documentation workload and limited therapeutic freedom, leading to a perceived ineffectiveness for patients' health outcomes. Thus, there was a discrepancy in the perceived effectiveness of the examined DMPs, causing a lower acceptance of the DMP CHD. Therefore, some of the respondents tended to enroll fewer patients into the DMP CHD or to drop out of the DMP CHD.
In order to increase the acceptance and sustainability of DMPs some elements of the DMP CHD as well as the remuneration and the documentation need to be reconsidered. Additionally, future studies on the acceptance of DMPs should differentiate between different DMPs in order to generate valid results.
在德国,2型糖尿病(T2DM)和冠心病(CHD)疾病管理项目(DMPs)中的大多数患者是由其全科医生(GP)登记入组的。在即将扩大DMPs的背景下,本研究的目的是了解全科医生目前对于DMPs中T2DM和CHD的有效性和接受度的经验和看法,并从全科医生的角度确定这些项目实施的有利和阻碍因素。
2020年8月和9月,对科隆大学医院教学实践中有DMPs经验的20名全科医生进行了半结构化焦点小组讨论访谈。根据Kuckartz的内容结构化定性内容分析法,对他们对DMPs中T2DM和CHD的期望、态度和看法进行了评估和分析。
受访者对DMP T2DM总体评价积极,因为其结构化治疗包括定期足部和眼部检查、与患者密切接触以及对改善健康结果的认知。受访者对DMP CHD的评价更为负面,原因是文档工作量大且部分不必要,以及治疗自由度有限,导致认为对患者健康结果无效。因此,在所检查的DMPs的有效性认知上存在差异,导致对DMP CHD的接受度较低。因此,一些受访者倾向于让较少的患者加入DMP CHD或退出DMP CHD。
为了提高DMPs的接受度和可持续性,需要重新考虑DMP CHD的一些要素以及报酬和文档工作。此外,未来关于DMPs接受度的研究应该区分不同的DMPs,以产生有效的结果。